T Ota, M Aihara, T Saeki, S Narumiya, M Araie - British Journal of Ophthalmology, 2007 - bjo.bmj.com Methods: C57BL/6J, and EP1, EP2, EP3 and postaglandin F (FP) receptor-deficient
wild-type (WT), EP1KO, EP2KO, EP3KO and FPKO, respectively mice were bred and
acclimatised under a 12-h (6:00–18:00) light–dark cycle. To evaluate ... Cited by 8 - Related articles - BL Direct - All 4 versions
A Kriatchko, G Zhan, N Cheruvu, SP … - Investigative Ophtalmology and Visual Science, 2003 - ARVO Commercial Relationships: A. Kriatchko, None; G. Zhan, None; N. Cheruvu, None;
SP Ayalasomayajula, None; CB Camras, Pharmacia Corporation C, R; RV Patil, None;
UB Kompella, None. ... Purpose:Bimatoprost is a prostaglandin analog that ... Cited by 2 - Related articles
- ►iovs.org T Ota, M Aihara, T Saeki, S Narumiya, M Araie - Investigative ophthalmology & visual science, 2006 - ARVO METHODS. Animals were bred and acclimatized in a 12-hour light-dark cycle. The
diurnal IOP variation was measured by a microneedle method in EP1, EP2, and EP3
receptor-deficient mice (EP1KO, EP2KO and EP3KO) and in their wild-type ... Cited by 10 - Related articles - BL Direct - All 3 versions
LB Cantor, J Hoop, D Wudunn, CW Yung, Y … - British Journal of Ophthalmology, 2007 - bjo.bmj.com Results: Bimatoprost acid (17-phenyl trinor prostaglandin F2α) was detected in
aqueous samples at a mean concentration of 5.0 nM at hour 1, 6.7 nM at hour 3
and 1.9 nM at hour 6 after bimatoprost treatment. After latanoprost ... Cited by 5 - Related articles - BL Direct - All 5 versions
- ►iovs.org T Ota, H Murata, E Sugimoto, M Aihara, M … - Investigative ophthalmology & visual science, 2005 - ARVO METHODS. Inbred adult ddY mice were bred and acclimatized under a 12-hour
light–dark cycle. With mice under general anesthesia, a microneedle method was
used to measure IOP. A single drop of 3 µL of either drug or vehicle ... Cited by 18 - Related articles - All 3 versions
- ►iovs.org JG Crowston, JD Lindsey, M Aihara, RN … - Investigative ophthalmology & visual science, 2004 - ARVO METHODS. Mean IOP difference between treated and untreated fellow eyes was
measured on three separate occasions, 2 hours after a 200-ng dose of latanoprost
to the right eye of homozygous (n = 9) and heterozygous (n = 15) FP ... Cited by 19 - Related articles - BL Direct - All 3 versions
E Brasnu, F Brignole-Baudouin, L Riancho, … - Current Eye Research, 2008 - informahealthcare.com Purpose: This study compared the toxicity profiles of three antiglaucoma
prostaglandin F2α analogs, latanoprost, travoprost, and bimatoprost which
contain benzalkonium chloride (BAK), with tafluprost, a new ... Cited by 6 - Related articles - BL Direct - All 4 versions
DC Dahlin, ER Craven, M Moster, K Sall, JT … - Investigative Ophtalmology and Visual Science, 2004 - ARVO Purpose: To measure the concentrations of bimatoprost (B) and bimatoprost free
acid (BFA) (17–phenyl–trinor–PGF 2 ) in the aqueous humor (AH) following
bilateral topical ocular administration of Lumigan® once daily for at ... Cited by 7 - Related articles
T Nakajima, T Matsugi, W Goto, M Kageyama, … - Biological & pharmaceutical bulletin, 2003 - J-STAGE To judge from the accumulating findings relating to latanoprost and other PGF 2a
derivatives, prostanoid FP-re- ceptor agonists are among the most promising
ocular-hy- potensive agents. To try to find prostanoid FP-receptor ago- ... Cited by 15 - Related articles - BL Direct - All 6 versions
